May 4, 2015 8:30 am EDT EyeGate Pharma Receives Positive Guidance From FDA on NDA Filing Requirements of EGP-437 for the Treatment of Anterior Uveitis
Mar 2, 2015 8:30 am EST Eyegate Pharmaceuticals Names Michael B. Raizman, MD, Consulting Chief Medical Officer